Suppr超能文献

肾内肾素-血管紧张素系统调节大鼠肾小球血管紧张素受体。

Intrarenal renin-angiotensin system modulates glomerular angiotensin receptors in the rat.

作者信息

Wilkes B M, Pion I, Sollott S, Michaels S, Kiesel G

机构信息

Department of Medicine, North Shore University Hospital, Manhasset, New York.

出版信息

Am J Physiol. 1988 Mar;254(3 Pt 2):F345-50. doi: 10.1152/ajprenal.1988.254.3.F345.

Abstract

The aim of this study was to test the hypothesis that the intrarenal renin-angiotensin system (RAS) modulates glomerular angiotensin II (ANG II) receptors. In one protocol ANG II receptors were measured 7 days after unilateral denervation of the left kidney in rats. There were 50% more receptors in the glomeruli from denervated compared with innervated kidneys (right, 1,037 +/- 108 vs. left, 1,556 +/- 143 fmol/mg; P less than 0.01), which was associated with a 63% reduction (P less than 0.01) in left renal vein renin. The differences in ANG II receptors between the left and right kidneys were no longer present when angiotensin-converting enzyme was inhibited with enalapril or when pharmacological amounts of ANG II (50 ng/min) were infused. In a second protocol, renal cortical renin content was raised in the left kidney by placing a 0.20-mm clip on the left renal artery (two-kidney, one-clip Goldblatt model). At 7 days, glomerular ANG II receptors were reduced by 72.3% in the clipped compared with the contralateral kidneys (right, 1,232 +/- 105 vs. left, 341 +/- 170 fmol/mg; P less than 0.01). The differences in ANG II receptors were no longer present after enalapril treatment. Pharmacological maneuvers that either blocked ANG II formation or increased circulating ANG II resulted in an equal number of ANG II receptors in the right and left kidneys. The data indicate that the intrarenal RAS modulates the density of glomerular ANG II receptors and is a more important receptor modulator than plasma ANG II.

摘要

本研究的目的是检验肾内肾素-血管紧张素系统(RAS)调节肾小球血管紧张素II(ANG II)受体这一假说。在一项实验方案中,对大鼠左肾进行单侧去神经支配7天后测量ANG II受体。与未去神经支配的肾脏(右侧)相比,去神经支配肾脏的肾小球中受体多50%(右侧,1037±108对左侧,1556±143 fmol/mg;P<0.01),这与左肾静脉肾素降低63%(P<0.01)相关。当用依那普利抑制血管紧张素转换酶或输注药理剂量的ANG II(50 ng/min)时,左右肾之间ANG II受体的差异不再存在。在第二项实验方案中,通过在左肾动脉放置一个0.20毫米的夹子(双肾,单夹戈德布拉特模型)来提高左肾的肾皮质肾素含量。7天时,与对侧肾脏相比,夹闭侧的肾小球ANG II受体减少了72.3%(右侧,1232±105对左侧,341±170 fmol/mg;P<0.01)。依那普利治疗后ANG II受体的差异不再存在。阻断ANG II形成或增加循环ANG II的药理操作导致左右肾中ANG II受体数量相等。数据表明,肾内RAS调节肾小球ANG II受体的密度,并且是比血浆ANG II更重要的受体调节因子。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验